These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 15247958)
1. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study). Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958 [TBL] [Abstract][Full Text] [Related]
2. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction. Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522 [TBL] [Abstract][Full Text] [Related]
3. Streptokinase and enoxaparin in the pre-hospital management of the ST-segment elevation acute myocardial infarction. Tatu-Chiţoiu G; Oprişan M; Cismara O; Marinescu R; Marinescu A Rom J Intern Med; 2002; 40(1-4):11-25. PubMed ID: 15526537 [TBL] [Abstract][Full Text] [Related]
4. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E; J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287 [TBL] [Abstract][Full Text] [Related]
6. Rapid infusion of streptokinase standard dose in acute myocardial infarction is followed by a higher rate of coronary reperfusion than standard protocol. Tatu-Chiţoiu G; Orha I; Teodorescu C; Flueraşu A; Serban L; Bumbu A Rom J Intern Med; 1997; 35(1-4):47-54. PubMed ID: 9562652 [TBL] [Abstract][Full Text] [Related]
7. Accelerated streptokinase--a new thrombolytic regimen in acute myocardial infarction. Tatu-Chiţoiu G; Teodorescu C; Flueraşu A; Căpraru P; Guran M; Dan M; Chioncel V; Bumbu A; Cornaciu S Rom J Intern Med; 1998; 36(3-4):183-96. PubMed ID: 10822515 [TBL] [Abstract][Full Text] [Related]
8. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E; J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial. Ghaffari S; Kazemi B; Golzari IG Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018 [TBL] [Abstract][Full Text] [Related]
11. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct]. Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835 [TBL] [Abstract][Full Text] [Related]
13. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis. Giraldez RR; Nicolau JC; Corbalan R; Gurfinkel EP; Juarez U; Lopez-Sendon J; Parkhomenko A; Molhoek P; Mohanavelu S; Morrow DA; Antman EM Eur Heart J; 2007 Jul; 28(13):1566-73. PubMed ID: 17562672 [TBL] [Abstract][Full Text] [Related]
14. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. Scirica BM; Morrow DA; Sadowski Z; Ruda M; Nicolau JC; Giugliano RP; Wiviott SD; Sabatine MS; Shui A; Antman EM; Braunwald E Eur Heart J; 2007 Sep; 28(17):2070-6. PubMed ID: 17600039 [TBL] [Abstract][Full Text] [Related]
15. [Effects of reperfusion and coronary reocclusion on the variability of heart rate in patients with acute myocardial infarction]. Pizzi C; Costa GM; Borghi A; Premuda G; Tondini C; Magri G; Cordioli E; Bugiardini R Cardiologia; 1999 Feb; 44(2):181-6. PubMed ID: 10208055 [TBL] [Abstract][Full Text] [Related]
16. Accelerated streptokinase in ST-elevation myocardial infarction--a Romanian (ASK-ROMANIA) multicenter registry. Tatu-Chiţoiu G; Dorobanţu M; Teodorescu C; Craiu E; Vintilă M; Minescu B; Burghină D; Stamate S; Serban L; Protopopescu T; Dan M; Căpraru P; Guran M; Istrătescu O; Vlădoianu M; Caea N Int J Cardiol; 2007 Nov; 122(3):216-23. PubMed ID: 17289177 [TBL] [Abstract][Full Text] [Related]
17. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis. Gabriel RS; White HD Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial. Lavi S; Cantor WJ; Casanova A; Tan MK; Yan AT; Džavík V; Fitchett D; Cohen EA; Borgundvaag B; Heffernan M; Ducas J; Goodman SG Am Heart J; 2012 Feb; 163(2):176-81.e2. PubMed ID: 22305834 [TBL] [Abstract][Full Text] [Related]
19. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. Fox KA; Antman EM; Montalescot G; Agewall S; SomaRaju B; Verheugt FW; Lopez-Sendon J; Hod H; Murphy SA; Braunwald E J Am Coll Cardiol; 2007 Jun; 49(23):2249-55. PubMed ID: 17560289 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a new streptokinase regimen with enoxaparin in acute myocardial infarction. Tatu-Chitoiu G; Teodorescu C; Dan M; Capraru P; Guran M; Istratescu O; Tatu-Chitoiu A; Bumbu A; Dorobantu M J Thromb Thrombolysis; 2003 Jun; 15(3):171-9. PubMed ID: 14739626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]